Kelly Constable

Kelly Constable

Director/Board Member bij ProTA Therapeutics Pty Ltd.

Health Technology
Finance
Consumer Services

Profiel

Ms. Kelly Constable is a Senior Advisor at Lumira Ventures and an Advisory Council at Medicines Australia.
She is on the Board of Directors at CERA Technologies Pty Ltd.
and ProTA Therapeutics Pty Ltd.
Ms. Constable was previously employed as a Venture partner by OneVentures Management Pty Ltd., a Board of Directors by Oculo Therapy LLC, a Chief strategy Officer by Omico Corp., a Board of Director & CEO by Genome One Pty Ltd., a Director of global marketing by Amgen AB, and a Senior product manager by Abbott Laboratories.
She received her undergraduate degree from the University of Tennessee.

Actieve functies van Kelly Constable

BedrijvenFunctieBegin
Consultant / Advisor 01-08-2020
Director/Board Member 01-02-2020
Director/Board Member 01-10-2018
Director/Board Member -
Alle actieve functies van Kelly Constable

Eerdere bekende functies van Kelly Constable

BedrijvenFunctieEinde
Consultant / Advisor 02-10-2023
OMICO CORPORATION Corporate Officer/Principal 02-12-2019
Director/Board Member 02-12-2019
Genome One Pty Ltd. Chief Executive Officer 31-08-2018
Director/Board Member 02-12-2016
Ervaring van Kelly Constable in detail bekijken

Opleiding van Kelly Constable

University of Tennessee Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Kelly Constable in detail bekijken

Connecties

81

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
ABBOTT LABORATORIES

Health Technology

OMICO CORPORATION

Finance

Bedrijven in privébezit8

Health Technology

Health Technology

Finance

Genome One Pty Ltd.

Health Technology

Health Technology

Commercial Services

Technology Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Kelly Constable